Skip to content
VLOCMarket desk
Switch to dark mode

고바이오랩

348150KOSDAQView the 바이오 R&D sectorTheme Bio & healthcare

2,720KRWMarket close of 10/28 (Wed)

Down -1.09%-30KRWMarket close of 10/28 (Wed)

Preliminary value — replaced once official KRX data for the same date is publishedClose of 10/29 (Thu)2,720KRWFlat 0.00%

Preliminary · replaced once official KRX data for the same date is published

Open
2,765
High
2,790
Low
2,635
Day range
Day range low 2,635 high 2,790, open 2,765, close 2,720, previous close 2,750
Volume
1×10K shares
30.69 million KRW 0.56× the 20-session average

Market close of 10/28 (Wed)

Where it sits in the 1-year range

1-year close range 2,610 to 6,720 won, 3% up from the low

3% of the way up from the lowest close in 1 year (252 sessions) · -59.5% from the high

Something to check

1 to check: operating loss

Loading

Free · no sign-inSource from 2021-05-17

Data dateMost recent closing data10/28 (Wed)
Market close data of 2026-10-28

Points to check

  • Earningsto check-8.1B KRWOperating income over the last four quarters -8.1B KRW (loss)Operating income, 8 quarters
  • Recent filingsnot verifiedOutside filing data coverage, so not verified
  • Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified

The other 2 are within the usual range

  • Daily move-1.09%usual range
  • Trading value0.6×usual range
See the full check report

Quarterly results · Q2 2026

Source: DART financials (Q4 derived as annual − three quarters) · Amended filing reflected
  • Revenue21.8B KRWRevenue bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    +23.8%
    vs. prior quarter
    +13.5%
  • Operating income-2.0B KRWOperating income bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    Still a loss
    vs. prior quarter
    Still a loss
  • Operating margin-9.2%Operating margin bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    +6.7 pp
    vs. prior quarter
    +4.7 pp

Quarterly operating income trend

As of the latest official close · 2026-10-28Valuation filing date · 2026-08-13
2021Q1 -3.3B KRW2026Q2 -2.0B KRWQ4 values are derived as the annual figure minus Q1–Q3. The value table marks them in the Type column.

Same sector · 바이오 R&D

Up +1.90%

· 40 of 64 stocks up, preferred shares excluded · trading value 209.6B KRW

Same sector · top by trading value
Stock20DChangeTrading value
알테오젠Close over the last 20 sessions -12.0%Up +2.06%52.9B KRW
디앤디파마텍Close over the last 20 sessions +2.3%Up +5.15%28.1B KRW
올릭스Close over the last 20 sessions -5.4%Up +7.40%22.0B KRW
리가켐바이오Close over the last 20 sessions -16.7%Up +3.60%13.4B KRW
프로티나Close over the last 20 sessions -3.9%Up +5.21%10.3B KRW

Schedule

  • Q3 report due · 11/16 (Mon) · in 17 days
  • Next data 10/30 (Fri) after 08:50

Related news

All news
Loading

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 83% of trading value, about 93% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.